 |
|
|
| |
COMPARATIVE EFFICACY OF FOSTEMSAVIR VERSUS IBALIZUMAB IN
HEAVILY TREATMENT-EXPERIENCED HIV PATIENTS
|
| |
| |
EACS 2021 Oct 27-30
Ian Jacob,1 Andrew Clark,2 Sarah-Jane Anderson,3 Melanie Schroeder2
1HEOR Ltd, Cardiff, UK; 2ViiV Healthcare, Brentford, UK; 3GlaxoSmithKline, Brentford, UK
|
| |
|
|
|
|
|
